399 related articles for article (PubMed ID: 36968113)
1. Deciphering the virulence factors, regulation, and immune response to
Shadan A; Pathak A; Ma Y; Pathania R; Singh RP
Front Cell Infect Microbiol; 2023; 13():1053968. PubMed ID: 36968113
[TBL] [Abstract][Full Text] [Related]
2. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
[TBL] [Abstract][Full Text] [Related]
3. Virulence role of the outer membrane protein CarO in carbapenem-resistant
Labrador-Herrera G; Pérez-Pulido AJ; Álvarez-Marín R; Casimiro-Soriguer CS; Cebrero-Cangueiro T; Morán-Barrio J; Pachón J; Viale AM; Pachón-Ibáñez ME
Virulence; 2020 Dec; 11(1):1727-1737. PubMed ID: 33300460
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
5. Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.
De Oliveira DMP; Forde BM; Phan MD; Steiner B; Zhang B; Zuegg J; El-Deeb IM; Li G; Keller N; Brouwer S; Harbison-Price N; Cork AJ; Bauer MJ; Alquethamy SF; Beatson SA; Roberts JA; Paterson DL; McEwan AG; Blaskovich MAT; Schembri MA; McDevitt CA; von Itzstein M; Walker MJ
mBio; 2022 Feb; 13(1):e0351721. PubMed ID: 35012353
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and molecular characterisations of carbapenem-resistant
Simo Tchuinte PL; Rabenandrasana MAN; Kowalewicz C; Andrianoelina VH; Rakotondrasoa A; Andrianirina ZZ; Enouf V; Ratsima EH; Randrianirina F; Collard JM
Antimicrob Resist Infect Control; 2019; 8():31. PubMed ID: 30792853
[TBL] [Abstract][Full Text] [Related]
7.
Dahdouh E; Hajjar M; Suarez M; Daoud Z
Front Cell Infect Microbiol; 2016; 6():163. PubMed ID: 27933276
[No Abstract] [Full Text] [Related]
8. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review.
Nguyen M; Joshi SG
J Appl Microbiol; 2021 Dec; 131(6):2715-2738. PubMed ID: 33971055
[TBL] [Abstract][Full Text] [Related]
9. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
Kempf M; Rolain JM
Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
[TBL] [Abstract][Full Text] [Related]
10. Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.
Meumann EM; Anstey NM; Currie BJ; Piera KA; Kenyon JJ; Hall RM; Davis JS; Sarovich DS
Microb Genom; 2019 Mar; 5(3):. PubMed ID: 30806611
[TBL] [Abstract][Full Text] [Related]
11. Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.
Rosales-Reyes R; Gayosso-Vázquez C; Fernández-Vázquez JL; Jarillo-Quijada MD; Rivera-Benítez C; Santos-Preciado JI; Alcántar-Curiel MD
PLoS One; 2017; 12(8):e0182899. PubMed ID: 28797068
[TBL] [Abstract][Full Text] [Related]
12. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies.
Law SKK; Tan HS
Microbiol Res; 2022 Jul; 260():127032. PubMed ID: 35483311
[TBL] [Abstract][Full Text] [Related]
13. Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection.
Mortensen BL; Skaar EP
Cell Microbiol; 2012 Sep; 14(9):1336-44. PubMed ID: 22640368
[TBL] [Abstract][Full Text] [Related]
14. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
15. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
Gordon NC; Wareham DW
Int J Antimicrob Agents; 2010 Mar; 35(3):219-26. PubMed ID: 20047818
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
18. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
Alharbe R; Almansour A; Kwon DH
Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
[TBL] [Abstract][Full Text] [Related]
20. Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter.
Godeux AS; Svedholm E; Barreto S; Potron A; Venner S; Charpentier X; Laaberki MH
mBio; 2022 Feb; 13(1):e0263121. PubMed ID: 35073754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
